Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza.
Phase of Trial: Phase II
Latest Information Update: 11 Jul 2013
At a glance
- Drugs DAS 181 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 16 Aug 2011 Status changed from active, no longer recruiting to completed, as reported in a NexBio media release.
- 15 Aug 2011 Topline data reported in a NexBio media release, and will also be presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy in September 2011.
- 05 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History